Pediatric cardiologists, interventional cardiologists, and cardiovascular surgeons from Columbia and Weill Cornell Medicine collaborate seamlessly to manage every form of heart disease in infants and children. Our teams work tirelessly to provide treatments for the most complex heart diseases with the latest imaging technologies, medical therapies, and surgical, transcatheter and hybrid procedures.
Pediatric Cardiology (Heart)
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
